National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 283967

History of Changes from the VAERS Wayback Machine

First Appeared on 12/31/2007

283967
VAERS Form:
Age:23.0
Gender:Female
Location:Florida
Vaccinated:2007-02-08
Onset:2007-02-08
Submitted:2007-06-14
Entered:2007-06-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0011U / 0 UN / UN

Administered by: Other      Purchased by: Unknown
Symptoms: Nausea, Vomiting

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Imuran (Azathioprine), Colazal, Seasonale
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type':

Write-up:Information has been received from a nurse concerning a 23 year old female patient who on 08-FEB-2007 was vaccinated with a first dose of Gardasil lot #654702/0011U. She received the second dose of Gardasil on an unspecified date. Concomitant therapy incl"uded azathioprine (IMURAN (azathioprine)), ethinyl estradiol (+) levonorgestrel (SEASONALE) and balsalazide disodium (COLAZAL). On 08-FEB-2007 later that day patient experienced nausea and vomiting. She was seen in the emergency room (ER) that night. She


Changed on 12/8/2009

283967 Before After
VAERS Form:
Age:23.0
Gender:Female
Location:Florida
Vaccinated:2007-02-08
Onset:2007-02-08
Submitted:2007-06-14
Entered:2007-06-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0011U / 0 UN / UN

Administered by: Other      Purchased by: Unknown Other
Symptoms: Nausea, Vomiting

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Imuran (Azathioprine), Colazal, Seasonale
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: Unknown
CDC 'Split Type': (blank) WAES0705USA02912

Write-up:Information has been received from a nurse concerning a 23 year old female patient who on 08-FEB-2007 was vaccinated with a first dose of Gardasil lot #654702/0011U. She received the second dose of Gardasil on an unspecified date. Concomitant therapy incl"uded included azathioprine (IMURAN (azathioprine)), ethinyl estradiol (+) levonorgestrel (SEASONALE) and balsalazide disodium (COLAZAL). On 08-FEB-2007 later that day patient experienced nausea and vomiting. She was seen in the emergency room (ER) that night. She was treated with an unnamed antinausea medication and intravenous fluids. She was sent home later. She had no adverse symptoms after the second injection. The patient recovered. The reporter felt that getting unnamed antinausea medication and intravenous fluids was to prevent patient from being serious and considered this as a serious other medical event. Additional information has been requested.


Changed on 3/2/2010

283967 Before After
VAERS Form:
Age:23.0
Gender:Female
Location:Florida
Vaccinated:2007-02-08
Onset:2007-02-08
Submitted:2007-06-14
Entered:2007-06-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0011U / 0 UN RA / UN IM

Administered by: Other Private      Purchased by: Other Public
Symptoms: Nausea, Vomiting

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: Imuran (Azathioprine), Colazal, Seasonale IMURAN, 100 mg; COLAZAL; SEASONALE
Current Illness: Menstruation irregular; Attention deficit/hyperactivity disorder
Preexisting Conditions: Unknown Unknown; Crohn''s disease; Infectious mononucleosis
Allergies:
Diagnostic Lab Data: Unknown Unknown; blood pressure, 02/09/07, 88/52, At the time of admission in ER; pulse oximetry, 02/09/07, 100%, on RA(At the time of discharge from ER); blood pressure, 02/09/07, 88/55, At the time of discharge from ER; temperature measurement, 0
CDC 'Split Type': WAES0705USA02912

Write-up:This is in follow-up to report(s) previously submitted on 6/14/2007. Information has been received from a nurse and from the emergency room medical record concerning a 23 year old female patient hair stylist with irregular menstruation, attention deficit/hyperactivity disorder and a history of anaemia, Crohn''s disease and infectious mononucleosis who on 08-FEB-2007 08-FEB-2007, at 14:15 PM was vaccinated IM in to right deltoid with a first dose of Gardasil lot #654702/0011U. She received the second dose of Gardasil on an unspecified date. Concomitant therapy included azathioprine (IMURAN (azathioprine)), ethinyl estradiol (+) levonorgestrel (SEASONALE) and balsalazide disodium (COLAZAL). On 08-FEB-2007 later that day patient experienced nausea and vomiting. She was seen in the emergency room (ER) that night. She was treated with an unnamed antinausea medication and intravenous fluids. She was sent home later. She had no adverse symptoms after the second injection. The patient recovered. The reporter felt that getting unnamed antinausea medication and intravenous fluids was to prevent patient from being serious and considered this as a serious other medical event. Additional information has been requested. In the follow up it was indicated that on 08-FEB-2007 patient began experiencing nausea and vomiting approximately 1/2 hour after receiving her first dose of GARDASIL was unable to hold down any food, fluids through the afternoon or evening. She went to the emergency room (ER) for evaluation and Intravenous (IV) fluids. ER record indicated she wen to the ER complained pain in her back, legs and abdomen. She had nausea, vomiting, fever and she was pale and weak. The pain characteristic was cramping, sharp and constant. She also had bodyache and myalgia, she was treated in the ER with TYLENOL gram by mouth, ANTIVERT 12.5 milligram intravenous (IV), TORADOL 30 milligram IV, ROCEPHIN 2 gram IV and 2 litters of normal saline solution (NSS) IV. Initially patient went to the ER her temperature measurement was 102.4 F, pulse was 135, resp


Changed on 4/7/2010

283967 Before After
VAERS Form:
Age:23.0
Gender:Female
Location:Florida
Vaccinated:2007-02-08
Onset:2007-02-08
Submitted:2007-06-14
Entered:2007-06-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0011U / 0 RA / IM

Administered by: Private      Purchased by: Public
Symptoms: Haemoglobin normal, Nausea, Vomiting, White blood cell count increased, Urine analysis normal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: IMURAN, 100 mg; COLAZAL; SEASONALE
Current Illness: Menstruation irregular; Attention deficit/hyperactivity disorder
Preexisting Conditions: Unknown; Crohn''s disease; Infectious mononucleosis
Allergies:
Diagnostic Lab Data: Unknown; blood pressure, 02/09/07, 88/52, At the time of admission in ER; pulse oximetry, 02/09/07, 100%, on RA(At the time of discharge from ER); blood pressure, 02/09/07, 88/55, At the time of discharge from ER; temperature measurement, 0
CDC 'Split Type': WAES0705USA02912

Write-up:This is in follow-up to report(s) previously submitted on 6/14/2007. Information has been received from a nurse and from the emergency room medical record concerning a 23 year old female hair stylist with irregular menstruation, attention deficit/hyperactivity disorder and a history of anaemia, Crohn''s disease and infectious mononucleosis who on 08-FEB-2007, at 14:15 PM was vaccinated IM in to right deltoid with a first dose of Gardasil lot #654702/0011U. She received the second dose of Gardasil on an unspecified date. Concomitant therapy included azathioprine (IMURAN (azathioprine)), ethinyl estradiol (+) levonorgestrel (SEASONALE) and balsalazide disodium (COLAZAL). On 08-FEB-2007 later that day patient experienced nausea and vomiting. She was seen in the emergency room (ER) that night. She was treated with an unnamed antinausea medication and intravenous fluids. She was sent home later. She had no adverse symptoms after the second injection. The patient recovered. The reporter felt that getting unnamed antinausea medication and intravenous fluids was to prevent patient from being serious and considered this as a serious other medical event. Additional information has been requested. In the follow up it was indicated that on 08-FEB-2007 patient began experiencing nausea and vomiting approximately 1/2 hour after receiving her first dose of GARDASIL was unable to hold down any food, fluids through the afternoon or evening. She went to the emergency room (ER) for evaluation and Intravenous (IV) fluids. ER record indicated she wen to the ER complained pain in her back, legs and abdomen. She had nausea, vomiting, fever and she was pale and weak. The pain characteristic was cramping, sharp and constant. She also had bodyache and myalgia, she was treated in the ER with TYLENOL gram by mouth, ANTIVERT 12.5 milligram intravenous (IV), TORADOL 30 milligram IV, ROCEPHIN 2 gram IV and 2 litters of normal saline solution (NSS) IV. Initially patient went to the ER her temperature measurement was 102.4 F, pulse was 135, resp


Changed on 1/4/2011

283967 Before After
VAERS Form:
Age:23.0
Gender:Female
Location:Florida
Vaccinated:2007-02-08
Onset:2007-02-08
Submitted:2007-06-14
Entered:2007-06-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0011U / 0 RA / IM

Administered by: Private      Purchased by: Public
Symptoms: Haemoglobin normal, Nausea, Vomiting, White blood cell count increased, Urine analysis normal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: IMURAN, 100 mg; COLAZAL; SEASONALE
Current Illness: Menstruation irregular; Attention deficit/hyperactivity disorder
Preexisting Conditions: Unknown; Crohn''s disease; Infectious mononucleosis
Allergies:
Diagnostic Lab Data: Unknown; blood pressure, 02/09/07, 88/52, At the time of admission in ER; pulse oximetry, 02/09/07, 100%, on RA(At the time of discharge from ER); blood pressure, 02/09/07, 88/55, At the time of discharge from ER; temperature measurement, 0 02/09/07, 102.4 Deg F, oral(At the time of admission to ER); WBC count, 02/09/07, 10.4; vital sign, 02/09/07, 135, Heart rate (At the admission time to ER); vital sign, 02/09/07, 108, Heart rate (At the time of discharge from ER); respiratory rate, 02/09/07, 19, Discharge time from ER; urinalysis, 02/09/07, Negat; hemoglobin, 02/09/07, 12.3; respiratory rate, 02/09/07, 20, At the time of admission to ER
CDC 'Split Type': WAES0705USA02912

Write-up:This is in follow-up to report(s) previously submitted on 6/14/2007. Information has been received from a nurse and from the emergency room medical record concerning a 23 year old female hair stylist with irregular menstruation, attention deficit/hyperactivity disorder and a history of anaemia, Crohn''s disease and infectious mononucleosis who on 08-FEB-2007, at 14:15 PM was vaccinated IM in to right deltoid with a first dose of Gardasil lot #654702/0011U. She received the second dose of Gardasil on an unspecified date. Concomitant therapy included azathioprine (IMURAN (azathioprine)), ethinyl estradiol (+) levonorgestrel (SEASONALE) and balsalazide disodium (COLAZAL). On 08-FEB-2007 later that day patient experienced nausea and vomiting. She was seen in the emergency room (ER) that night. She was treated with an unnamed antinausea medication and intravenous fluids. She was sent home later. She had no adverse symptoms after the second injection. The patient recovered. The reporter felt that getting unnamed antinausea medication and intravenous fluids was to prevent patient from being serious and considered this as a serious other medical event. Additional information has been requested. In the follow up it was indicated that on 08-FEB-2007 patient began experiencing nausea and vomiting approximately 1/2 hour after receiving her first dose of GARDASIL was unable to hold down any food, fluids through the afternoon or evening. She went to the emergency room (ER) for evaluation and Intravenous (IV) fluids. ER record indicated she wen to the ER complained pain in her back, legs and abdomen. She had nausea, vomiting, fever and she was pale and weak. The pain characteristic was cramping, sharp and constant. She also had bodyache and myalgia, she was treated in the ER with TYLENOL gram by mouth, ANTIVERT 12.5 milligram intravenous (IV), TORADOL 30 milligram IV, ROCEPHIN 2 gram IV and 2 litters of normal saline solution (NSS) IV. Initially patient went to the ER her temperature measurement was 102.4 F, pulse was 135, resp respiration was 20 and blood pressure was 88/52. Patient''s blood pressure measurement was 88/55, heart rate was 108 and respiration was 19 at the time of discharge from the ER. Pulse Oximetry was 100% on room air (RA). On 09-FEB-2007 the patient recovered. On an unspecified day she received the second dose of GARDASIL and had no adverse symptoms. The reporter no longer considered the events to be other important medical events. Additional information is not expected.


Changed on 6/14/2014

283967 Before After
VAERS Form:
Age:23.0
Gender:Female
Location:Florida
Vaccinated:2007-02-08
Onset:2007-02-08
Submitted:2007-06-14
Entered:2007-06-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0011U / 0 RA / IM

Administered by: Private      Purchased by: Public
Symptoms: Haemoglobin normal, Nausea, Vomiting, White blood cell count increased, Urine analysis normal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: IMURAN, 100 mg; COLAZAL; SEASONALE
Current Illness: Menstruation irregular; Attention deficit/hyperactivity disorder
Preexisting Conditions: Unknown; Crohn''s disease; Infectious mononucleosis
Allergies:
Diagnostic Lab Data: Unknown; blood pressure, 02/09/07, 88/52, At the time of admission in ER; pulse oximetry, 02/09/07, 100%, on RA(At the time of discharge from ER); blood pressure, 02/09/07, 88/55, At the time of discharge from ER; temperature measurement, 02/09/07, 102.4 Deg F, oral(At the time of admission to ER); WBC count, 02/09/07, 10.4; vital sign, 02/09/07, 135, Heart rate (At the admission time to ER); vital sign, 02/09/07, 108, Heart rate (At the time of discharge from ER); respiratory rate, 02/09/07, 19, Discharge time from ER; urinalysis, 02/09/07, Negat; hemoglobin, 02/09/07, 12.3; respiratory rate, 02/09/07, 20, At the time of admission to ER
CDC 'Split Type': WAES0705USA02912

Write-up:This is in follow-up to report(s) previously submitted on 6/14/2007. Information has been received from a nurse and from the emergency room medical record concerning a 23 year old female hair stylist with irregular menstruation, attention deficit/hyperactivity disorder and a history of anaemia, Crohn''s disease and infectious mononucleosis who on 08-FEB-2007, at 14:15 PM was vaccinated IM in to right deltoid with a first dose of Gardasil lot #654702/0011U. She received the second dose of Gardasil on an unspecified date. Concomitant therapy included azathioprine (IMURAN (azathioprine)), ethinyl estradiol (+) levonorgestrel (SEASONALE) and balsalazide disodium (COLAZAL). On 08-FEB-2007 later that day patient experienced nausea and vomiting. She was seen in the emergency room (ER) that night. She was treated with an unnamed antinausea medication and intravenous fluids. She was sent home later. She had no adverse symptoms after the second injection. The patient recovered. The reporter felt that getting unnamed antinausea medication and intravenous fluids was to prevent patient from being serious and considered this as a serious other medical event. Additional information has been requested. In the follow up it was indicated that on 08-FEB-2007 patient began experiencing nausea and vomiting approximately 1/2 hour after receiving her first dose of GARDASIL was unable to hold down any food, fluids through the afternoon or evening. She went to the emergency room (ER) for evaluation and Intravenous (IV) fluids. ER record indicated she wen to the ER complained pain in her back, legs and abdomen. She had nausea, vomiting, fever and she was pale and weak. The pain characteristic was cramping, sharp and constant. She also had bodyache and myalgia, she was treated in the ER with TYLENOL gram by mouth, ANTIVERT 12.5 milligram intravenous (IV), TORADOL 30 milligram IV, ROCEPHIN 2 gram IV and 2 litters of normal saline solution (NSS) IV. Initially patient went to the ER her temperature measurement was 102.4 F, pulse was 135, respiration was 20 and blood pressure was 88/52. Patient''s blood pressure measurement was 88/55, heart rate was 108 and respiration was 19 at the time of discharge from the ER. Pulse Oximetry was 100% on room air (RA). On 09-FEB-2007 the patient recovered. On an unspecified day she received the second dose of GARDASIL and had no adverse symptoms. The reporter no longer considered the events to be other important medical events. Additional information is not expected.


Changed on 5/14/2017

283967 Before After
VAERS Form:
Age:23.0
Gender:Female
Location:Florida
Vaccinated:2007-02-08
Onset:2007-02-08
Submitted:2007-06-14
Entered:2007-06-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0011U / 0 RA / IM

Administered by: Private      Purchased by: Public
Symptoms: Haemoglobin normal, Nausea, Vomiting, White blood cell count increased, Urine analysis normal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: IMURAN, 100 mg; COLAZAL; SEASONALE
Current Illness: Menstruation irregular; Attention deficit/hyperactivity disorder
Preexisting Conditions: Unknown; Crohn''s disease; Infectious mononucleosis
Allergies:
Diagnostic Lab Data: Unknown; blood pressure, 02/09/07, 88/52, At the time of admission in ER; pulse oximetry, 02/09/07, 100%, on RA(At the time of discharge from ER); blood pressure, 02/09/07, 88/55, At the time of discharge from ER; temperature measurement, 02/09/07, 102.4 Deg F, oral(At the time of admission to ER); WBC count, 02/09/07, 10.4; vital sign, 02/09/07, 135, Heart rate (At the admission time to ER); vital sign, 02/09/07, 108, Heart rate (At the time of discharge from ER); respiratory rate, 02/09/07, 19, Discharge time from ER; urinalysis, 02/09/07, Negat; hemoglobin, 02/09/07, 12.3; respiratory rate, 02/09/07, 20, At the time of admission to ER
CDC 'Split Type': WAES0705USA02912

Write-up:This is in follow-up to report(s) previously submitted on 6/14/2007. Information has been received from a nurse and from the emergency room medical record concerning a 23 year old female hair stylist with irregular menstruation, attention deficit/hyperactivity disorder and a history of anaemia, Crohn''s disease and infectious mononucleosis who on 08-FEB-2007, at 14:15 PM was vaccinated IM in to right deltoid with a first dose of Gardasil lot #654702/0011U. She received the second dose of Gardasil on an unspecified date. Concomitant therapy included azathioprine (IMURAN (azathioprine)), ethinyl estradiol (+) levonorgestrel (SEASONALE) and balsalazide disodium (COLAZAL). On 08-FEB-2007 later that day patient experienced nausea and vomiting. She was seen in the emergency room (ER) that night. She was treated with an unnamed antinausea medication and intravenous fluids. She was sent home later. She had no adverse symptoms after the second injection. The patient recovered. The reporter felt that getting unnamed antinausea medication and intravenous fluids was to prevent patient from being serious and considered this as a serious other medical event. Additional information has been requested. In the follow up it was indicated that on 08-FEB-2007 patient began experiencing nausea and vomiting approximately 1/2 hour after receiving her first dose of GARDASIL was unable to hold down any food, fluids through the afternoon or evening. She went to the emergency room (ER) for evaluation and Intravenous (IV) fluids. ER record indicated she wen to the ER complained pain in her back, legs and abdomen. She had nausea, vomiting, fever and she was pale and weak. The pain characteristic was cramping, sharp and constant. She also had bodyache and myalgia, she was treated in the ER with TYLENOL gram by mouth, ANTIVERT 12.5 milligram intravenous (IV), TORADOL 30 milligram IV, ROCEPHIN 2 gram IV and 2 litters of normal saline solution (NSS) IV. Initially patient went to the ER her temperature measurement was 102.4 F, pulse was 135, respiration was 20 and blood pressure was 88/52. Patient''s blood pressure measurement was 88/55, heart rate was 108 and respiration was 19 at the time of discharge from the ER. Pulse Oximetry was 100% on room air (RA). On 09-FEB-2007 the patient recovered. On an unspecified day she received the second dose of GARDASIL and had no adverse symptoms. The reporter no longer considered the events to be other important medical events. Additional information is not expected.


Changed on 9/14/2017

283967 Before After
VAERS Form:(blank) 1
Age:23.0
Gender:Female
Location:Florida
Vaccinated:2007-02-08
Onset:2007-02-08
Submitted:2007-06-14
Entered:2007-06-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0011U / 0 1 RA / IM

Administered by: Private      Purchased by: Public
Symptoms: Haemoglobin normal, Nausea, Vomiting, White blood cell count increased, Urine analysis normal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? No
Previous Vaccinations:
Other Medications: IMURAN, 100 mg; COLAZAL; SEASONALE
Current Illness: Menstruation irregular; Attention deficit/hyperactivity disorder
Preexisting Conditions: Unknown; Crohn''s disease; Infectious mononucleosis
Allergies:
Diagnostic Lab Data: Unknown; blood pressure, 02/09/07, 88/52, At the time of admission in ER; pulse oximetry, 02/09/07, 100%, on RA(At the time of discharge from ER); blood pressure, 02/09/07, 88/55, At the time of discharge from ER; temperature measurement, 02/09/07, 102.4 Deg F, oral(At the time of admission to ER); WBC count, 02/09/07, 10.4; vital sign, 02/09/07, 135, Heart rate (At the admission time to ER); vital sign, 02/09/07, 108, Heart rate (At the time of discharge from ER); respiratory rate, 02/09/07, 19, Discharge time from ER; urinalysis, 02/09/07, Negat; hemoglobin, 02/09/07, 12.3; respiratory rate, 02/09/07, 20, At the time of admission to ER
CDC 'Split Type': WAES0705USA02912

Write-up:This is in follow-up to report(s) previously submitted on 6/14/2007. Information has been received from a nurse and from the emergency room medical record concerning a 23 year old female hair stylist with irregular menstruation, attention deficit/hyperactivity disorder and a history of anaemia, Crohn''s disease and infectious mononucleosis who on 08-FEB-2007, at 14:15 PM was vaccinated IM in to right deltoid with a first dose of Gardasil lot #654702/0011U. She received the second dose of Gardasil on an unspecified date. Concomitant therapy included azathioprine (IMURAN (azathioprine)), ethinyl estradiol (+) levonorgestrel (SEASONALE) and balsalazide disodium (COLAZAL). On 08-FEB-2007 later that day patient experienced nausea and vomiting. She was seen in the emergency room (ER) that night. She was treated with an unnamed antinausea medication and intravenous fluids. She was sent home later. She had no adverse symptoms after the second injection. The patient recovered. The reporter felt that getting unnamed antinausea medication and intravenous fluids was to prevent patient from being serious and considered this as a serious other medical event. Additional information has been requested. In the follow up it was indicated that on 08-FEB-2007 patient began experiencing nausea and vomiting approximately 1/2 hour after receiving her first dose of GARDASIL was unable to hold down any food, fluids through the afternoon or evening. She went to the emergency room (ER) for evaluation and Intravenous (IV) fluids. ER record indicated she wen to the ER complained pain in her back, legs and abdomen. She had nausea, vomiting, fever and she was pale and weak. The pain characteristic was cramping, sharp and constant. She also had bodyache and myalgia, she was treated in the ER with TYLENOL gram by mouth, ANTIVERT 12.5 milligram intravenous (IV), TORADOL 30 milligram IV, ROCEPHIN 2 gram IV and 2 litters of normal saline solution (NSS) IV. Initially patient went to the ER her temperature measurement was 102.4 F, pulse was 135, respiration was 20 and blood pressure was 88/52. Patient''s blood pressure measurement was 88/55, heart rate was 108 and respiration was 19 at the time of discharge from the ER. Pulse Oximetry was 100% on room air (RA). On 09-FEB-2007 the patient recovered. On an unspecified day she received the second dose of GARDASIL and had no adverse symptoms. The reporter no longer considered the events to be other important medical events. Additional information is not expected.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=283967&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166